Cargando…

Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation

Heterozygous mutations in GATA2 underlie different syndromes, previously described as monocytopenia and mycobacterial avium complex infection (MonoMAC); dendritic cell, monocytes, B- and NK lymphocytes deficiency (DCML); lymphedema, deafness and myelodysplasia (Emberger syndrome) and familiar myelod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lübking, Anna, Vosberg, Sebastian, Konstandin, Nikola P., Dufour, Annika, Graf, Alexander, Krebs, Stefan, Blum, Helmut, Weber, Axel, Lenhoff, Stig, Ehinger, Mats, Spiekermann, Karsten, Greif, Philipp A., Cammenga, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672090/ https://www.ncbi.nlm.nih.gov/pubmed/26716079 http://dx.doi.org/10.1016/j.lrr.2015.10.001

Ejemplares similares

ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome
por: West, Robert R., et al.
Publicado: (2022)

The new and recurrent FLT3 juxtamembrane deletion mutation shows a dominant negative effect on the wild-type FLT3 receptor
por: Sandhöfer, Nadine, et al.
Publicado: (2016)

Development of acoustically isolated extracellular plasma vesicles for biomarker discovery in allogeneic hematopoietic stem cell transplantation
por: Lim, Hooi Ching, et al.
Publicado: (2021)

Fusion gene detection by RNA-sequencing complements diagnostics of acute myeloid leukemia and identifies recurring NRIP1-MIR99AHG rearrangements
por: Kerbs, Paul, et al.
Publicado: (2021)

Clonal evolution of acute myeloid leukemia from diagnosis to relapse
por: Vosberg, Sebastian, et al.
Publicado: (2019)

FAT1 expression and mutations in adult acute lymphoblastic leukemia
por: Neumann, M, et al.
Publicado: (2014)

The clinical mutatome of core binding factor leukemia
por: Opatz, Sabrina, et al.
Publicado: (2020)

Examining the neurodevelopmental and motor phenotypes of Bohring-Opitz syndrome (ASXL1) and Bainbridge-Ropers syndrome (ASXL3)
por: Ayoub, Maya C., et al.
Publicado: (2023)

Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1–BAP1 complex
por: Balasubramani, Anand, et al.
Publicado: (2015)

Functional and cancer genomics of ASXL family members
por: Katoh, M
Publicado: (2013)

ASXL1 plays an important role in erythropoiesis
por: Shi, Hui, et al.
Publicado: (2016)

ASXL1/2 mutations and myeloid malignancies
por: Medina, Edward A., et al.
Publicado: (2022)

ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation
por: Hartmann, Luise, et al.
Publicado: (2016)

Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Lycke, Jan, et al.
Publicado: (2020)

Mutational spectrum of adult T-ALL
por: Neumann, Martin, et al.
Publicado: (2014)

Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network
por: Xia, Yu-Kun, et al.
Publicado: (2020)

ASXL1 mutations in Chinese patients with essential thrombocythemia
por: Nie, Yan-Bo, et al.
Publicado: (2018)

Loss of Asxl2 leads to myeloid malignancies in mice
por: Li, Jianping, et al.
Publicado: (2017)

Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish
por: Gjini, Evisa, et al.
Publicado: (2019)

Expanding our knowledge of conditions associated with the ASXL gene family
por: Russell, Bianca, et al.
Publicado: (2013)

Role of ASXL1 mutation in impaired hematopoiesis and cellular senescence
por: Uni, Masahiro, et al.
Publicado: (2018)

Hyperventilation-athetosis in ASXL3 deficiency (Bainbridge-Ropers) syndrome
por: Dad, Rubina, et al.
Publicado: (2017)

Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid Leukaemia
por: Batcha, Aarif M. N., et al.
Publicado: (2019)

Long-term follow-up of cytogenetically normal CEBPA-mutated AML
por: Pastore, Friederike, et al.
Publicado: (2014)

Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
por: Abdel-Wahab, Omar, et al.
Publicado: (2013)

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
por: Asada, Shuhei, et al.
Publicado: (2018)

Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1
por: Daou, Salima, et al.
Publicado: (2018)

Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish
por: Fang, Xiao, et al.
Publicado: (2021)

ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen
por: Wang, Liang, et al.
Publicado: (2021)

“ASXL1”-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms
por: Gleitz, Hélène F.E., et al.
Publicado: (2022)

A Novel Mutation in GATA3 Gene in a Case of Hypoparathyroidism, Deafness, and Renal Dysplasia Syndrome
por: Prabhu, Pooja Prakash, et al.
Publicado: (2023)

Clinical Auditory Phenotypes Associated with GATA3 Gene Mutations in Familial Hypoparathyroidism-deafness-renal Dysplasia Syndrome
por: Wang, Li, et al.
Publicado: (2017)

BAP1/ASXL1 recruitment and activation for H2A deubiquitination
por: Sahtoe, Danny D., et al.
Publicado: (2016)

SETBP1 Mutations Drive Leukemic Transformation in ASXL1-Mutated MDS
por: Inoue, Daichi, et al.
Publicado: (2014)

Asxl2(−/−) Mice Exhibit De Novo Cardiomyocyte Production during Adulthood
por: Brunner, Rachel, et al.
Publicado: (2016)

Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation
por: Nagase, Reina, et al.
Publicado: (2018)

ASXL2 regulates hematopoiesis in mice and its deficiency promotes myeloid expansion
por: Madan, Vikas, et al.
Publicado: (2018)

Pathological ASXL1 Mutations and Protein Variants Impair Neural Crest Development
por: Matheus, Friederike, et al.
Publicado: (2019)

ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
por: Micol, Jean-Baptiste, et al.
Publicado: (2017)

Deregulation of tumor suppressive ASXL1−PTEN/AKT axis in myeloid malignancies
por: Cao, Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0prbd5pnmqdf17bford4sa9h26